Search Results < Endocrinology & Metabolism

Endocrinology & Metabolism

140 results

News
News 8 On Call: Keto Diet
News 8 On Call: Keto Diet
16 Jan 2020
News
Have the Blockbuster Diabetes Drug Trials Been Biased?
Have the Blockbuster Diabetes Drug Trials Been Biased?
15 Jan 2020
News
Cell Death Channel Found Within ATP Synthase Monomer, Study Finds
Cell Death Channel Found Within ATP Synthase Monomer, Study Finds
6 Jan 2020
News
Top 3 dieting trends of 2020
Top 3 dieting trends of 2020
2 Jan 2020
News
12 Diets You Should Never Try, According to Health Experts
Plus the ones that really work.
19 Dec 2019
News
Healthy Gifts That Are Doctor Recommended
Healthy Gifts That Are Doctor Recommended
29 Nov 2019
News
Bill to cap insulin costs passes IL House committee
Bill to cap insulin costs passes IL House committee
12 Nov 2019
News
Yale Diabetes Research Center Pilot and Feasibility Project Grants Available
Deadline extended.
12 Nov 2019
News
News 8 On Call: New policy for children with severe obesity
We have the answers to questions many are asking about a new American Academy of Pediatrics policy for children with severe obesity.
31 Oct 2019
News
A Symposium Honoring Dr. Robert Stanley Sherwin's Scientific Achievements, on Oct. 25
This symposium will honor Robert Sherwin, MD, C.N.H. Long Professor Emeritus, for the breadth and depth of his scientific contributions to the field of diabetes and metabolism.
16 Oct 2019
News
A Tribute to Dr. Robert Sherwin on Oct. 25 for His Scientific Achievements
The Sherwin Symposium will be held October 25, 2019, 8:30 a.m. - 4 p.m., at the Park Street Auditorium, 55 Park Street, New Haven, CT.
9 Oct 2019
News
This Is Your Body On The Keto Diet
The ketogenic diet isn’t new. But over the past few years, it has emerged as one of the most popular and polarizing ways to lose weight.
8 Oct 2019
News
Insogna Awarded Shared Instrument Grant
Karl Insogna, MD, FACP, Ensign Professor of Medicine (Endocrinology); director, Yale Bone Center; and associate director, Yale Center for X-Linked Hypophosphatemia, has received funding from Yale University’s Core Facilities Request for Equipment Replacement and Upgrade Program to acquire an UltraFocus digital x-ray cabinet by Faxitron®.
4 Oct 2019
News
Experimental drug that targets liver fat may help prevent diabetes
An experimental drug has reversed the build-up of fat in the liver and lowered blood levels of fatty substances including cholesterol in non-human primates. The build-up of fat in the liver, known as non-alcoholic fatty liver disease, affects 1 in 3 people and can lead to type 2 diabetes as well as heart and kidney disease.
2 Oct 2019
News
Burosumab Shows Sustained Efficacy in Rare Inherited Rickets
Burosumab (Crysvita, Ultragenyx), an anti-FGF23 monoclonal antibody, shows long-term safety and efficacy out to almost 2 years in the treatment of X-linked hypophosphatemia (XLH), a rare, inherited form of rickets, according to the latest findings from a phase 3 clinical trial.
2 Oct 2019
News
New Drug Helps Combat Metabolic Syndrome
A new drug developed at Yale reduces a host of abnormalities associated with metabolic syndrome, an obesity-born condition that afflicts one of three adults in the United States, researchers report in the journal Science Translational Medicine.
2 Oct 2019
News
When Diet and Exercise Aren’t Enough
Sometimes no matter what you do, the weight doesn’t come off. The good news? If you’re dealing with obesity, you have more treatment options than you realize.
1 Oct 2019
News
Treating adolescent obesity: The evidence behind behavioral, pharmacological, and weight loss surgery options
SILVER SPRING, Md.--As rates of adolescent obesity continue to rise, choice of treatment needs to be guided by the severity of obesity, psychosocial factors, comorbidities and patient's age and pubertal status, according to a new paper published online in the Journal of the American Medical Association (JAMA).
30 Sep 2019
News
DAPA-HF analyses provide further insights into dapagliflozin efficacy
Analyses of metabolic, biomarker, and other outcomes from the DAPA-HF trial presented at the 55th EASD Annual Meeting in Barcelona, Spain, provide additional insights into the efficacy of dapagliflozin in patients with heart failure (HF).
27 Sep 2019
News
Use of insulin among older adults with type 2 diabetes not aligned with national guidelines
Patients with type 2 diabetes who were in poor health were more likely to continue taking insulin after age 75 than their counterparts in better health, according to Kaiser Permanente research published today in JAMA Internal Medicine.
23 Sep 2019